ID   FRK_HUMAN               Reviewed;         505 AA.
AC   P42685; B4DY49; Q13128; Q9NTR5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   12-OCT-2022, entry version 212.
DE   RecName: Full=Tyrosine-protein kinase FRK;
DE            EC=2.7.10.2;
DE   AltName: Full=FYN-related kinase;
DE   AltName: Full=Nuclear tyrosine protein kinase RAK;
DE   AltName: Full=Protein-tyrosine kinase 5;
GN   Name=FRK; Synonyms=PTK5, RAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=7696183;
RA   Cance W.G., Craven R.J., Bergman M., Xu L.H., Alitalo K., Liu E.T.;
RT   "Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.";
RL   Cell Growth Differ. 5:1347-1355(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoid tissue;
RX   PubMed=7510261; DOI=10.1016/0378-1119(94)90817-6;
RA   Lee J., Wang Z., Luoh S.-M., Wood W.I., Scadden D.T.;
RT   "Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-
RT   encoding gene.";
RL   Gene 138:247-251(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8099900; DOI=10.1002/ijc.2910540409;
RA   Cance W.G., Craven R.J., Weiner T.M., Liu E.T.;
RT   "Novel protein kinases expressed in human breast cancer.";
RL   Int. J. Cancer 54:571-577(1993).
RN   [8]
RP   INTERACTION WITH RB1.
RX   PubMed=7664264;
RA   Craven R.J., Cance W.G., Liu E.T.;
RT   "The nuclear tyrosine kinase Rak associates with the retinoblastoma protein
RT   pRb.";
RL   Cancer Res. 55:3969-3972(1995).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   FUNCTION, INTERACTION WITH PTEN, AND MUTAGENESIS OF LYS-262.
RX   PubMed=19345329; DOI=10.1016/j.ccr.2009.02.012;
RA   Yim E.-K., Peng G., Dai H., Hu R., Li K., Lu Y., Mills G.B.,
RA   Meric-Bernstam F., Hennessy B.T., Craven R.J., Lin S.-Y.;
RT   "Rak functions as a tumor suppressor by regulating PTEN protein stability
RT   and function.";
RL   Cancer Cell 15:304-314(2009).
RN   [11]
RP   REVIEW ON FUNCTION.
RX   PubMed=19652529; DOI=10.4161/cc.8.17.9389;
RA   Brauer P.M., Tyner A.L.;
RT   "RAKing in AKT: a tumor suppressor function for the intracellular tyrosine
RT   kinase FRK.";
RL   Cell Cycle 8:2728-2732(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-100; ARG-122 AND LEU-133.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase that negatively
CC       regulates cell proliferation. Positively regulates PTEN protein
CC       stability through phosphorylation of PTEN on 'Tyr-336', which in turn
CC       prevents its ubiquitination and degradation, possibly by reducing its
CC       binding to NEDD4. May function as a tumor suppressor.
CC       {ECO:0000269|PubMed:19345329}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Interacts (via the SH3-domain) with PTEN. Interacts with RB1.
CC       {ECO:0000269|PubMed:19345329, ECO:0000269|PubMed:7664264}.
CC   -!- INTERACTION:
CC       P42685; Q12982: BNIP2; NbExp=8; IntAct=EBI-1383583, EBI-752094;
CC       P42685; P60484: PTEN; NbExp=7; IntAct=EBI-1383583, EBI-696162;
CC       P42685; P06400: RB1; NbExp=3; IntAct=EBI-1383583, EBI-491274;
CC       P42685; Q15427: SF3B4; NbExp=4; IntAct=EBI-1383583, EBI-348469;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7696183}. Nucleus
CC       {ECO:0000269|PubMed:7696183}. Note=Predominantly found in the nucleus,
CC       with a small fraction found in the cell periphery.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P42685-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P42685-2; Sequence=VSP_056496, VSP_056497;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in epithelial derived cell
CC       lines and tissues, especially normal liver, kidney, breast and colon.
CC       {ECO:0000269|PubMed:7696183}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U22322; AAC50116.1; -; mRNA.
DR   EMBL; U00803; AAA18284.1; -; mRNA.
DR   EMBL; AK302264; BAG63611.1; -; mRNA.
DR   EMBL; AL021451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL121963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48241.1; -; Genomic_DNA.
DR   EMBL; BC012916; AAH12916.1; -; mRNA.
DR   CCDS; CCDS5103.1; -. [P42685-1]
DR   PIR; I38396; I38396.
DR   RefSeq; NP_002022.1; NM_002031.2. [P42685-1]
DR   RefSeq; XP_005266937.1; XM_005266880.4. [P42685-1]
DR   RefSeq; XP_005266938.1; XM_005266881.2. [P42685-1]
DR   RefSeq; XP_005266939.1; XM_005266882.4. [P42685-1]
DR   RefSeq; XP_011533955.1; XM_011535653.2. [P42685-1]
DR   RefSeq; XP_011533956.1; XM_011535654.2. [P42685-1]
DR   RefSeq; XP_011533957.1; XM_011535655.2. [P42685-1]
DR   RefSeq; XP_016866134.1; XM_017010645.1. [P42685-1]
DR   AlphaFoldDB; P42685; -.
DR   SMR; P42685; -.
DR   BioGRID; 108726; 11.
DR   IntAct; P42685; 44.
DR   MINT; P42685; -.
DR   STRING; 9606.ENSP00000476145; -.
DR   BindingDB; P42685; -.
DR   ChEMBL; CHEMBL4223; -.
DR   DrugBank; DB01254; Dasatinib.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB08896; Regorafenib.
DR   DrugBank; DB15035; Zanubrutinib.
DR   DrugCentral; P42685; -.
DR   GuidetoPHARMACOLOGY; 2025; -.
DR   iPTMnet; P42685; -.
DR   PhosphoSitePlus; P42685; -.
DR   BioMuta; FRK; -.
DR   DMDM; 1169745; -.
DR   CPTAC; CPTAC-2793; -.
DR   EPD; P42685; -.
DR   jPOST; P42685; -.
DR   MassIVE; P42685; -.
DR   MaxQB; P42685; -.
DR   PaxDb; P42685; -.
DR   PeptideAtlas; P42685; -.
DR   PRIDE; P42685; -.
DR   ProteomicsDB; 5498; -.
DR   ProteomicsDB; 55538; -. [P42685-1]
DR   TopDownProteomics; P42685-1; -. [P42685-1]
DR   Antibodypedia; 32472; 581 antibodies from 34 providers.
DR   DNASU; 2444; -.
DR   Ensembl; ENST00000606080.2; ENSP00000476145.1; ENSG00000111816.8. [P42685-1]
DR   GeneID; 2444; -.
DR   KEGG; hsa:2444; -.
DR   MANE-Select; ENST00000606080.2; ENSP00000476145.1; NM_002031.3; NP_002022.1.
DR   UCSC; uc003pwi.2; human. [P42685-1]
DR   CTD; 2444; -.
DR   DisGeNET; 2444; -.
DR   GeneCards; FRK; -.
DR   HGNC; HGNC:3955; FRK.
DR   HPA; ENSG00000111816; Tissue enhanced (choroid).
DR   MIM; 606573; gene.
DR   neXtProt; NX_P42685; -.
DR   OpenTargets; ENSG00000111816; -.
DR   PharmGKB; PA28373; -.
DR   VEuPathDB; HostDB:ENSG00000111816; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   GeneTree; ENSGT00940000156987; -.
DR   HOGENOM; CLU_000288_7_2_1; -.
DR   InParanoid; P42685; -.
DR   OMA; SSHEGWW; -.
DR   OrthoDB; 539311at2759; -.
DR   PhylomeDB; P42685; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; P42685; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   SignaLink; P42685; -.
DR   SIGNOR; P42685; -.
DR   BioGRID-ORCS; 2444; 6 hits in 1103 CRISPR screens.
DR   ChiTaRS; FRK; human.
DR   GeneWiki; Fyn-related_kinase; -.
DR   GenomeRNAi; 2444; -.
DR   Pharos; P42685; Tchem.
DR   PRO; PR:P42685; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P42685; protein.
DR   Bgee; ENSG00000111816; Expressed in jejunal mucosa and 157 other tissues.
DR   Genevisible; P42685; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd10369; SH2_Src_Frk; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR035805; SH2_Frk.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; SH2 domain; SH3 domain;
KW   Transferase; Tumor suppressor; Tyrosine-protein kinase.
FT   CHAIN           1..505
FT                   /note="Tyrosine-protein kinase FRK"
FT                   /id="PRO_0000088097"
FT   DOMAIN          42..110
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          116..208
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          234..491
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        354
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         240..248
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         262
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         178
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         387
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q922K9"
FT   VAR_SEQ         1..13
FT                   /note="MSNICQRLWEYLE -> MDSTSLLPNPWIR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056496"
FT   VAR_SEQ         14..155
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056497"
FT   VARIANT         100
FT                   /note="I -> V (in dbSNP:rs34704018)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041702"
FT   VARIANT         122
FT                   /note="G -> R (in dbSNP:rs3756772)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_006283"
FT   VARIANT         133
FT                   /note="S -> L (in dbSNP:rs34064900)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041703"
FT   MUTAGEN         262
FT                   /note="K->R: Loss of ability to phosphorylate PTEN."
FT                   /evidence="ECO:0000269|PubMed:19345329"
FT   CONFLICT        115
FT                   /note="P -> A (in Ref. 1; AAC50116)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   505 AA;  58254 MW;  06EC050DDBCD930B CRC64;
     MSNICQRLWE YLEPYLPCLS TEADKSTVIE NPGALCSPQS QRHGHYFVAL FDYQARTAED
     LSFRAGDKLQ VLDTLHEGWW FARHLEKRRD GSSQQLQGYI PSNYVAEDRS LQAEPWFFGA
     IGRSDAEKQL LYSENKTGSF LIRESESQKG EFSLSVLDGA VVKHYRIKRL DEGGFFLTRR
     RIFSTLNEFV SHYTKTSDGL CVKLGKPCLK IQVPAPFDLS YKTVDQWEID RNSIQLLKRL
     GSGQFGEVWE GLWNNTTPVA VKTLKPGSMD PNDFLREAQI MKNLRHPKLI QLYAVCTLED
     PIYIITELMR HGSLQEYLQN DTGSKIHLTQ QVDMAAQVAS GMAYLESRNY IHRDLAARNV
     LVGEHNIYKV ADFGLARVFK VDNEDIYESR HEIKLPVKWT APEAIRSNKF SIKSDVWSFG
     ILLYEIITYG KMPYSGMTGA QVIQMLAQNY RLPQPSNCPQ QFYNIMLECW NAEPKERPTF
     ETLRWKLEDY FETDSSYSDA NNFIR
//
